miR-182-5p Delivered by Plasma Exosomes Promotes Sevoflurane-Induced Neuroinflammation and Cognitive Dysfunction in Aged Rats with Postoperative Cognitive Dysfunction by Targeting Brain-Derived Neurotrophic Factor and Activating NF-κB Pathway

Neurotox Res. 2022 Dec;40(6):1902-1912. doi: 10.1007/s12640-022-00597-1. Epub 2022 Oct 29.

Abstract

The objective of this study was to discuss the possible mechanism and effect of miR-182-5p delivered by plasma exosomes on sevoflurane-induced neuroinflammation and cognitive disorder in aged rats with postoperative cognitive dysfunction (POCD). Firstly, aged POCD rat models were constructed by sevoflurane anesthesia and superior mesenteric artery occlusion. Subsequently, exosomes and miR-182-5p were inhibited by injection of GW4869 and miR-182-5p-sponge, respectively. Then, exosomes were extracted from the plasma of rats in each group, followed by the determination of the morphology and diameters of exosomes as well as the expression of exosome markers CD63 and CD81 by transmission electron microscopy (TEM), nanoparticle tracking analysis (NTA), and Western blot. Besides, the Morris water maze (MWM) and fear conditioning test were used to evaluate the learning and memory ability of rats; Western blot to detect the expression levels of neurotrophic factors (brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF)) as well as NF-κB pathway-related proteins (p65 and p-p65) in rat hippocampal tissues or PC-12 cells; qRT-PCR to assess the expression levels of miR-182-5p and BDNF in rat plasma, plasma exosomes, hippocampal tissues, and PC-12 cells; ELISA to evaluate the levels of tumor necrosis factor (TNF)-α, interleukin (IL)-6, and IL-1β in rat hippocampal tissues; and dual-luciferase reporter assay to verify the targeting relationship between miR-182-5p and BDNF. After examination, the results were obtained as follows. miR-182-5p expression was up-regulated in POCD rats and could be delivered by plasma exosomes. Inhibition of plasma exosomes or miR-182-5p could significantly ameliorate learning and memory disorders; decrease the levels of pro-inflammatory cytokines TNF-α, IL-6, and IL-1β; increase the expression of BDNF and NGF; and inhibit the activity of NF-κB signaling pathway in POCD rat hippocampus. In addition, miR-182-5p could also target and inhibit BDNF. All in all, miR-182-5p delivered by plasma exosomes promotes sevoflurane-induced neuroinflammation and cognitive dysfunction in aged POCD rats by targeting BDNF and activating the NF-κB pathway.

Keywords: Brain-derived neurotrophic factor (BDNF); Cognitive dysfunction; NF-κB pathway; Neuroinflammation; Plasma exosomes; miR-182-5p.

MeSH terms

  • Animals
  • Brain-Derived Neurotrophic Factor
  • Cognitive Dysfunction* / chemically induced
  • Cognitive Dysfunction* / metabolism
  • Exosomes* / metabolism
  • Interleukin-6
  • MicroRNAs* / metabolism
  • NF-kappa B / metabolism
  • Nerve Growth Factor
  • Neuroinflammatory Diseases
  • Postoperative Cognitive Complications* / chemically induced
  • Rats
  • Sevoflurane / toxicity
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • NF-kappa B
  • Sevoflurane
  • Brain-Derived Neurotrophic Factor
  • Nerve Growth Factor
  • Tumor Necrosis Factor-alpha
  • Interleukin-6
  • MicroRNAs
  • MIRN182 microRNA, rat